spacer
spacer

PDBsum entry 2abl

Go to PDB code: 
protein links
Transferase PDB id
2abl

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
163 a.a. *
Waters ×40
* Residue conservation analysis
PDB id:
2abl
Name: Transferase
Title: Sh3-sh2 domain fragment of human bcr-abl tyrosine kinase
Structure: Abl tyrosine kinase. Chain: a. Fragment: sh3-sh2 domain fragment. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Cell_line: bl21. Gene: abl sh3-sh2. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
Resolution:
2.50Å     R-factor:   0.183     R-free:   0.270
Authors: H.-J.Nam,C.A.Frederick
Key ref:
H.J.Nam et al. (1996). Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism. Structure, 4, 1105-1114. PubMed id: 8805596 DOI: 10.1016/S0969-2126(96)00116-5
Date:
17-Nov-96     Release date:   04-Sep-97    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00519  (ABL1_HUMAN) -  Tyrosine-protein kinase ABL1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1130 a.a.
163 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.2  - non-specific protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1016/S0969-2126(96)00116-5 Structure 4:1105-1114 (1996)
PubMed id: 8805596  
 
 
Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism.
H.J.Nam, W.G.Haser, T.M.Roberts, C.A.Frederick.
 
  ABSTRACT  
 
BACKGROUND. The Abl nonreceptor tyrosine kinase is implicated in a range of cellular processes and its transforming variants are involved in human leukemias. The N-terminal regulatory region of the Abl protein contains Src homology domains SH2 and SH3 which have been shown to be important for the regulation of its activity in vivo. These domains are often found together in the same protein and biochemical data suggest that the functions of one domain can be influenced by the other. RESULTS. We have determined the crystal structure of the Abl regulatory region containing the SH3 and SH2 domains. In general, the individual domains are very similar to those of previously solved structures, although the Abl SH2 domain contains a loop which is extended so that one side of the resulting phosphotyrosine-binding pocket is open. In our structure the protein exists as a monomer with no intermolecular contacts to which a biological function may be attributed. However, there is a significant intramolecular contact between a loop of the SH3 domain and the extended loop of the SH2 domain. This contact surface includes the SH2 loop segment that is responsible for binding the phosphate moiety of phosphotyrosine-containing proteins and is therefore critical for orienting peptide interactions. CONCLUSIONS. The crystal structure of the composite Abl SH3-SH2 domain provides the first indication of how SH2 and SH3 domains communicate with each other within the same molecule and why the presence of one directly influences the activity of the other. This is the first clear evidence that these two domains are in contact with each other. The results suggest that this direct interaction between the two domains may affect the ligand binding properties of the SH2 domain, thus providing an explanation for biochemical and functional data concerning the Bcr-Abl kinase.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. Schematic diagram and surface structure of the Abl SH3–SH2 regulatory region. (a) Richardson diagram of the Abl SH3–SH2 protein showing the relative positions of the SH3 and SH2 domains in one molecule. The SH2 domain is at the top of the figure and the SH3 domain at the bottom. In the SH2 domain the β strands are shown in red and the α helices in green; in the SH3 domain the β strands are in yellow. The secondary structure elements are numbered according to the convention of Eck, et al. [31] with individual residues identified by their position within each element or connecting loop; this numbering is used throughout. (The figure was made with the program MOLSCRIPT [51].) (b) The molecular surface of the Abl SH3–SH2 structure. The surface is colored according to the local electrostatic potential, ranging from blue (the most positive region) to red (the most negative). The putative phosphotyrosine-binding pocket and a hydrophobic (pTyr + 3 pocket are indicated. Important residues for the ligand binding of the SH3 domain are also indicated. Figure 2. Schematic diagram and surface structure of the Abl SH3–SH2 regulatory region. (a) Richardson diagram of the Abl SH3–SH2 protein showing the relative positions of the SH3 and SH2 domains in one molecule. The SH2 domain is at the top of the figure and the SH3 domain at the bottom. In the SH2 domain the β strands are shown in red and the α helices in green; in the SH3 domain the β strands are in yellow. The secondary structure elements are numbered according to the convention of Eck, et al. [[3]31] with individual residues identified by their position within each element or connecting loop; this numbering is used throughout. (The figure was made with the program MOLSCRIPT [[4]51].) (b) The molecular surface of the Abl SH3–SH2 structure. The surface is colored according to the local electrostatic potential, ranging from blue (the most positive region) to red (the most negative). The putative phosphotyrosine-binding pocket and a hydrophobic (pTyr + 3 pocket are indicated. Important residues for the ligand binding of the SH3 domain are also indicated. (The figure was made using the program GRASP [[5]52].)
Figure 6.
Figure 6. Ramachandram plot of the refined structure. Glycine and non-glycine ψ, φ pairs are designated by triangles and squares, respectively. Disallowed, generously allowed, favorable and most favorable regions are indicated by progressively darker shading. Of all the residues, 89% are in the most favorable regions and none of the residues are in disallowed regions. Figure 6. Ramachandram plot of the refined structure. Glycine and non-glycine ψ, φ pairs are designated by triangles and squares, respectively. Disallowed, generously allowed, favorable and most favorable regions are indicated by progressively darker shading. Of all the residues, 89% are in the most favorable regions and none of the residues are in disallowed regions.
 
  The above figures are reprinted by permission from Cell Press: Structure (1996, 4, 1105-1114) copyright 1996.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
18004789 M.Kosloff, and R.Kolodny (2008).
Sequence-similar, structure-dissimilar protein pairs in the PDB.
  Proteins, 71, 891-902.  
16891373 H.X.Zhou (2006).
Quantitative relation between intermolecular and intramolecular binding of pro-rich peptides to SH3 domains.
  Biophys J, 91, 3170-3181.  
15894543 S.Radtke, S.Haan, A.Jörissen, H.M.Hermanns, S.Diefenbach, T.Smyczek, H.Schmitz-Vandeleur, P.C.Heinrich, I.Behrmann, and C.Haan (2005).
The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression.
  J Biol Chem, 280, 25760-25768.  
16247798 W.K.Kim, and J.C.Ison (2005).
Survey of the geometric association of domain-domain interfaces.
  Proteins, 61, 1075-1088.  
12654251 B.Nagar, O.Hantschel, M.A.Young, K.Scheffzek, D.Veach, W.Bornmann, B.Clarkson, G.Superti-Furga, and J.Kuriyan (2003).
Structural basis for the autoinhibition of c-Abl tyrosine kinase.
  Cell, 112, 859-871.
PDB codes: 1opj 1opk 1opl
12654249 M.Azam, R.R.Latek, and G.Q.Daley (2003).
Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL.
  Cell, 112, 831-843.  
12411494 A.Klejman, S.J.Schreiner, M.Nieborowska-Skorska, A.Slupianek, M.Wilson, T.E.Smithgall, and T.Skorski (2002).
The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.
  EMBO J, 21, 5766-5774.  
12027890 M.Hörtner, U.Nielsch, L.M.Mayr, P.C.Heinrich, and S.Haan (2002).
A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor.
  Eur J Biochem, 269, 2516-2526.  
10209040 M.Nieborowska-Skorska, M.A.Wasik, A.Slupianek, P.Salomoni, T.Kitamura, B.Calabretta, and T.Skorski (1999).
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
  J Exp Med, 189, 1229-1242.  
10090735 Q.Xu, J.Zheng, R.Xu, G.Barany, and D.Cowburn (1999).
Flexibility of interdomain contacts revealed by topological isomers of bivalent consolidated ligands to the dual Src homology domain SH(32) of abelson.
  Biochemistry, 38, 3491-3497.  
9892643 R.Xu, B.Ayers, D.Cowburn, and T.W.Muir (1999).
Chemical ligation of folded recombinant proteins: segmental isotopic labeling of domains for NMR studies.
  Proc Natl Acad Sci U S A, 96, 388-393.  
9566119 D.C.Dalgarno, M.C.Botfield, and R.J.Rickles (1997).
SH3 domains and drug design: ligands, structure, and biological function.
  Biopolymers, 43, 383-400.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer